Vivani Medical VANI Income Statement (2014-2026)

NASDAQ VANI
$1.41 +0.02 (+1.44%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter)
0.00M1.60M
Cost of Revenue (Quarter)
Gross Profit (Quarter)
0.13M
Operating items
Research & Development (Quarter)
2.87M2.98M2.68M3.20M3.86M4.43M3.96M3.86M4.44M4.71M0.75M3.51M0.77M4.30M4.22M1.24M1.08M1.18M4.39M4.46M
Selling, General & Administrative (Quarter)
0.62M0.57M1.23M0.88M1.58M3.36M2.65M3.14M2.70M1.51M2.50M2.17M2.11M2.16M2.34M2.70M2.21M2.18M2.43M2.42M
Restructuring Costs (Quarter)
0.27M0.26M0.30M-0.01M0.21M0.33M0.29M0.28M0.37M0.58M
Other Operating Expenses (Quarter)
-0.01M-0.02M-0.02M6.87M0.51M0.28M0.48M0.36M0.19M0.19M0.33M0.27M0.01M0.26M0.32M0.20M3.18M0.04M0.50M
Operating Expenses (Quarter)
3.48M3.55M3.91M4.09M5.44M7.79M6.60M7.00M7.14M6.22M6.23M5.68M6.31M6.46M6.56M7.46M6.72M6.81M6.82M6.87M
Operating Income (Quarter)
-3.48M-1.29M-3.91M-4.09M-5.44M-7.79M-6.60M-7.00M-7.14M-6.22M-6.23M-5.68M-6.31M-6.46M-6.56M-7.46M-6.72M-6.81M-6.82M-6.87M
EBIT (Quarter)
-3.48M-1.29M-3.91M-4.09M-5.44M-7.79M-6.60M-7.00M-7.14M-6.22M-6.23M-5.68M-6.31M-6.46M-6.56M-7.46M-6.72M-6.81M-6.82M-6.87M
Non-operating items
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)
Net income details
EBT (Quarter)
-3.54M-901.29M-3.95M-4.09M-5.44M-62.62M-6.60M-37.99M-7.14M-5.42M-36.25M-14.76M-15.11M-76.04M-33.48M-15.06M-9.79M-82.64M-9.97M-30.86M
Profit After Tax (Quarter)
-3.49M-1.28M-3.92M-4.10M1.42M-7.28M-6.32M-6.53M-6.80M-6.03M-6.04M-5.36M-6.04M-6.05M-6.30M-7.14M-6.53M-6.65M-6.78M-6.37M
Income from Continuing Operations (Quarter)
-3.54M-901.29M-3.95M-4.09M-5.44M-62.62M-6.60M-37.99M-7.14M-5.42M-36.25M-14.76M-15.11M-76.04M-33.48M-15.06M-9.79M-82.64M-9.97M-30.86M
Consolidated Net Income (Quarter)
-3.54M-901.29M-3.95M-4.09M-5.44M-62.62M-6.60M-37.99M-7.14M-5.42M-36.25M-14.76M-15.11M-76.04M-33.48M-15.06M-9.79M-82.64M-9.97M-30.86M
Income towards Parent Company (Quarter)
-3.54M-901.29M-3.95M-4.09M-5.44M-62.62M-6.60M-37.99M-7.14M-5.42M-36.25M-14.76M-15.11M-76.04M-33.48M-15.06M-9.79M-82.64M-9.97M-30.86M
Net Income towards Common Stockholders (Quarter)
-3.54M-901.29M-3.95M-4.09M-5.44M-62.62M-6.60M-37.99M-7.14M-5.42M-36.25M-14.76M-15.11M-76.04M-33.48M-15.06M-9.79M-82.64M-9.97M-30.86M
Additional items
EPS (Basic) (Quarter)
-0.27-82.39-300.70-311.13-143.40-0.00M-130.06-0.75-140.53-106.54-694.34-0.27-0.27-0.00M-0.57-0.25-0.16-1.32-0.12-0.35
EPS (Diluted) (Quarter)
-104.62-0.03M-107.32-110.82-141.49-0.00M-130.06-747.93-140.53-106.54-0.69-0.27-0.27-0.00M-0.57-0.25-0.16-1.32-0.12-0.35
Shares Outstanding (Quarter)
13.14M10.94M0.01M0.01M0.04M0.04M0.05M50.80M0.05M0.05M0.05M55.02M55.25M0.05M59.24M59.24M59.71M62.39M81.27M87.09M
Shares Outstanding (Diluted) (Quarter)
0.03M0.03M0.04M0.04M0.04M0.04M0.05M0.05M0.05M0.05M52.20M55.02M55.25M0.05M59.24M59.24M59.71M62.39M81.27M87.09M
Shares Outstanding (Entity) (Quarter)
13.14M10.94M0.01M0.01M0.04M0.04M0.05M50.80M0.05M0.05M0.05M55.20M55.27M0.05M59.24M59.24M61.51M62.39M84.65M89.41M
EBITDA (Quarter)
-3.48M-1.29M-3.91M-4.09M-5.44M-7.79M-6.60M-7.00M-7.14M-6.22M-6.23M-5.68M-6.31M-6.46M-6.56M-7.46M-6.72M-6.81M-6.82M-6.87M
Interest Expenses (Quarter)
0.05M900.00M0.04M54.83M30.99M-0.80M30.02M9.08M8.80M69.58M26.93M7.59M3.06M75.83M3.16M23.98M